220 related articles for article (PubMed ID: 23143416)
1. Active site profiling reveals coupling between domains in SRC-family kinases.
Krishnamurty R; Brigham JL; Leonard SE; Ranjitkar P; Larson ET; Dale EJ; Merritt EA; Maly DJ
Nat Chem Biol; 2013 Jan; 9(1):43-50. PubMed ID: 23143416
[TBL] [Abstract][Full Text] [Related]
2. Divergent modulation of Src-family kinase regulatory interactions with ATP-competitive inhibitors.
Leonard SE; Register AC; Krishnamurty R; Brighty GJ; Maly DJ
ACS Chem Biol; 2014 Aug; 9(8):1894-905. PubMed ID: 24946274
[TBL] [Abstract][Full Text] [Related]
3. Allosteric Modulation of Src Family Kinases with ATP-Competitive Inhibitors.
Register AC; Chakraborty S; Maly DJ
Methods Mol Biol; 2017; 1636():79-89. PubMed ID: 28730474
[TBL] [Abstract][Full Text] [Related]
4. Targeting Dynamic ATP-Binding Site Features Allows Discrimination between Highly Homologous Protein Kinases.
Chakraborty S; Inukai T; Fang L; Golkowski M; Maly DJ
ACS Chem Biol; 2019 Jun; 14(6):1249-1259. PubMed ID: 31038916
[TBL] [Abstract][Full Text] [Related]
5. How ATP-Competitive Inhibitors Allosterically Modulate Tyrosine Kinases That Contain a Src-like Regulatory Architecture.
Fang L; Vilas-Boas J; Chakraborty S; Potter ZE; Register AC; Seeliger MA; Maly DJ
ACS Chem Biol; 2020 Jul; 15(7):2005-2016. PubMed ID: 32479050
[TBL] [Abstract][Full Text] [Related]
6. Structural basis for selective inhibition of Src family kinases by PP1.
Liu Y; Bishop A; Witucki L; Kraybill B; Shimizu E; Tsien J; Ubersax J; Blethrow J; Morgan DO; Shokat KM
Chem Biol; 1999 Sep; 6(9):671-8. PubMed ID: 10467133
[TBL] [Abstract][Full Text] [Related]
7. C-terminal Src kinase-homologous kinase (CHK), a unique inhibitor inactivating multiple active conformations of Src family tyrosine kinases.
Chong YP; Chan AS; Chan KC; Williamson NA; Lerner EC; Smithgall TE; Bjorge JD; Fujita DJ; Purcell AW; Scholz G; Mulhern TD; Cheng HC
J Biol Chem; 2006 Nov; 281(44):32988-99. PubMed ID: 16959780
[TBL] [Abstract][Full Text] [Related]
8. Structural basis of Src tyrosine kinase inhibition with a new class of potent and selective trisubstituted purine-based compounds.
Dalgarno D; Stehle T; Narula S; Schelling P; van Schravendijk MR; Adams S; Andrade L; Keats J; Ram M; Jin L; Grossman T; MacNeil I; Metcalf C; Shakespeare W; Wang Y; Keenan T; Sundaramoorthi R; Bohacek R; Weigele M; Sawyer T
Chem Biol Drug Des; 2006 Jan; 67(1):46-57. PubMed ID: 16492148
[TBL] [Abstract][Full Text] [Related]
9. Bivalent Inhibitors of c-Src Tyrosine Kinase That Bind a Regulatory Domain.
Johnson TK; Soellner MB
Bioconjug Chem; 2016 Jul; 27(7):1745-9. PubMed ID: 27266260
[TBL] [Abstract][Full Text] [Related]
10. Bivalent inhibitors of the tyrosine kinases ABL and SRC: determinants of potency and selectivity.
Hill ZB; Perera BG; Maly DJ
Mol Biosyst; 2011 Feb; 7(2):447-56. PubMed ID: 21060940
[TBL] [Abstract][Full Text] [Related]
11. Structures of Src-family tyrosine kinases.
Sicheri F; Kuriyan J
Curr Opin Struct Biol; 1997 Dec; 7(6):777-85. PubMed ID: 9434895
[TBL] [Abstract][Full Text] [Related]
12. Novel mechanism of regulation of the non-receptor protein tyrosine kinase Csk: insights from NMR mapping studies and site-directed mutagenesis.
Shekhtman A; Ghose R; Wang D; Cole PA; Cowburn D
J Mol Biol; 2001 Nov; 314(1):129-38. PubMed ID: 11724538
[TBL] [Abstract][Full Text] [Related]
13. Phosphorylation-dependent interactions between ADAM15 cytoplasmic domain and Src family protein-tyrosine kinases.
Poghosyan Z; Robbins SM; Houslay MD; Webster A; Murphy G; Edwards DR
J Biol Chem; 2002 Feb; 277(7):4999-5007. PubMed ID: 11741929
[TBL] [Abstract][Full Text] [Related]
14. Src tyrosine kinase is a novel direct effector of G proteins.
Ma YC; Huang J; Ali S; Lowry W; Huang XY
Cell; 2000 Sep; 102(5):635-46. PubMed ID: 11007482
[TBL] [Abstract][Full Text] [Related]
15. Tyrosine Kinase Activation and Conformational Flexibility: Lessons from Src-Family Tyrosine Kinases.
Meng Y; Pond MP; Roux B
Acc Chem Res; 2017 May; 50(5):1193-1201. PubMed ID: 28426203
[TBL] [Abstract][Full Text] [Related]
16. Selective Targeting of SH2 Domain-Phosphotyrosine Interactions of Src Family Tyrosine Kinases with Monobodies.
Kükenshöner T; Schmit NE; Bouda E; Sha F; Pojer F; Koide A; Seeliger M; Koide S; Hantschel O
J Mol Biol; 2017 May; 429(9):1364-1380. PubMed ID: 28347651
[TBL] [Abstract][Full Text] [Related]
17. Crystal structure of the Src family kinase Hck SH3-SH2 linker regulatory region supports an SH3-dominant activation mechanism.
Alvarado JJ; Betts L; Moroco JA; Smithgall TE; Yeh JI
J Biol Chem; 2010 Nov; 285(46):35455-61. PubMed ID: 20810664
[TBL] [Abstract][Full Text] [Related]
18. New Structural Perspectives in G Protein-Coupled Receptor-Mediated Src Family Kinase Activation.
Berndt S; Liebscher I
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34204297
[TBL] [Abstract][Full Text] [Related]
19. Inhibitor scaffolds as new allele specific kinase substrates.
Kraybill BC; Elkin LL; Blethrow JD; Morgan DO; Shokat KM
J Am Chem Soc; 2002 Oct; 124(41):12118-28. PubMed ID: 12371851
[TBL] [Abstract][Full Text] [Related]
20. Endogenous and synthetic inhibitors of the Src-family protein tyrosine kinases.
Chong YP; Ia KK; Mulhern TD; Cheng HC
Biochim Biophys Acta; 2005 Dec; 1754(1-2):210-20. PubMed ID: 16198159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
